Renal Cancer - Results from #1820

Nivolumab in Combination with Stereotactic Body Radiotherapy in Pretreated Patients with Metastatic Renal Cell Carcinoma. Results of the Phase II NIVES Study. October 6, 2021

Nobel Winner Dr. James P. “Jim” Allison to Give Keynote Address at IKCS 2021 October 5, 2021

Inflammatory response markers and survival prediction in patients with renal cell carcinoma. October 5, 2021

CD44 Is Involved in Sunitinib Resistance and Poor Progression-free Survival After Sunitinib Treatment of Renal Cell Carcinoma. October 5, 2021

Limited Association Between Ascorbate Concentrations and Vitamin C Transporters in Renal Cell Carcinoma Cells and Clinical Samples. October 4, 2021

Morphomics Can Predict Oncological Features and Survival of Metastatic Renal Cell Carcinoma After Cytoreductive Nephrectomy. October 4, 2021

Predictive radiomics signature for treatment response to nivolumab in patients with advanced renal cell carcinoma. October 1, 2021

Eosinophilic features in clear cell renal cell carcinoma correlate with outcomes of immune checkpoint and angiogenesis blockade. October 1, 2021

Evaluation of the association of health care system access with kidney cancer surgical outcomes for hispanic and non-hispanic white patients. September 30, 2021

Somatic mutations as preoperative predictors of metastases in patients with localized clear cell renal cell carcinoma - An exploratory analysis. September 30, 2021

Early detection of kidney cancer using urinary proteins: a truly non-invasive strategy. September 29, 2021

Use of Second-line Immunotherapy in Control Arms of Randomized Clinical Trials in Kidney Cancer: A Systematic Review. September 29, 2021

Overexpression of IRF3 Predicts Poor Prognosis in Clear Cell Renal Cell Carcinoma. September 28, 2021

Identifying preoperative predictors of operative time and their impact on outcomes in robot-assisted partial nephrectomy. September 28, 2021

Analgesic use and the risk of renal cell carcinoma - Findings from the Consortium for the Investigation of Renal Malignancies (CONFIRM) study. September 27, 2021

Prognostic significance of extent of venous tumor thrombus in patients with non-metastatic renal cell carcinoma: Results from a Canadian multi-institutional collaborative. September 27, 2021

Functional succinate dehydrogenase deficiency is a common adverse feature of clear cell renal cancer. September 27, 2021

PBRM1 loss in kidney cancer unbalances the proximal tubule master transcription factor hub to repress proximal tubule differentiation. September 24, 2021

Clinical Outcomes and Adverse Events after First-Line Treatment in Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-Analysis. September 23, 2021

External validation of the REMARCC model for the selection of cytoreductive nephrectomy in patients with primary metastatic renal cell carcinoma: A multicenter retrospective study. September 23, 2021

Page 92 of 456